The Montreux Healthcare Fund has secured a material upsizing to its current debt facility for the Active Care Group. The Facility, which will be secured at asset level, continues the current BlackRock European Middle Market Private Debt relationship with the addition of the global investment group Caisse de dépôt et placement du Québec (CDPQ). Rothschild & Co. offered strategic and debt advisory throughout the process.

The facility will allow the fund to spearhead a wide-ranging growth strategy laid out to investors on 11th February 2021, a plan which aims to increase the Active Care Group’s EBITDA by 40% in the next couple of years.

Oliver Harris, CEO, Montreux Capital Management (UK) stated: “Montreux Capital Management is pleased to deepen its relationship with the BlackRock European Middle Market Private Debt team and to add further collaboration with CDPQ. The relationship with these large institutional investors is a ringing endorsement for the Active Care Group’s strategy over the coming years as the business grows further.”

Hedley Goldberg, Global Head of Healthcare Services at Rothchild & Co. stated: “Active Care Group’s refinancing establishes a long-term, supportive capital structure for the business as it continues its expansion in order to meet demand for the critical services that it provides to those in its care. As part of the refinancing, CDPQ has joined BlackRock Asset Management as a lender to the Group, further enhancing the resources available to it. The transaction evidences the continued strong level of support available to high quality businesses within the UK healthcare services industry and
represents a key phase in Active Care Group’s evolution. We’re delighted to have provided the company with both strategic and debt advisory services, illustrating the integrated capabilities of our healthcare services advisory platform.”

Find Us

Thameside House
Hurst Road
East Molesey

T: + 44 (0) 1932 860 140

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.